首页
探索
nav.journalClub
趋势
更多
synapse
⌘+K
语言
简体中文
简体中文
miRNAs mediated Hsa21 gene suppression as potential therapeutic agent for Down syndrome: molecular dynamics and MM/PBSA-based study | Synapse
March 3, 2026
miRNAs mediated Hsa21 gene suppression as potential therapeutic agent for Down syndrome: molecular dynamics and MM/PBSA-based study
PS
Prashasti Sinha
AY
Anil Kumar Yadav
Key Points
Gene suppression has potential as a therapeutic approach for Down syndrome, focusing on miRNAs.
Analysis shows that molecular dynamics simulations highlight the role of miRNAs in regulating gene activity.
The study employs MM/PBSA methods to assess interactions between miRNAs and Hsa21 genes in detail.
Understanding these interactions may enable future development of targeted treatments for Down syndrome.
Mark Helpful
Like
Save
Bookmark
Relay
Share
Cite This Study
Copy
Sinha et al. (Wed,) studied this question.
synapsesocial.com/papers/69a75c2fc6e9836116a24c70
https://doi.org/https://doi.org/10.1007/s00894-026-06634-6
Mark Helpful
Like
Save
Bookmark
Relay
Share